Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
67.2M
-
Shares change
-
+1.73M
-
Total reported value, excl. options
-
$4.04B
-
Value change
-
+$108M
-
Number of buys
-
103
-
Number of sells
-
-98
-
Price
-
$60.21
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q1 2015
236 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q1 2015.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.2M shares
of 71.9M outstanding shares and own 93.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.53M shares), Neuberger Berman Group LLC (5.52M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.13M shares), FRANKLIN RESOURCES INC (4.37M shares), BlackRock Fund Advisors (4.23M shares), STATE STREET CORP (2.81M shares), BAMCO INC /NY/ (2.54M shares), KALMAR INVESTMENTS INC /DE/ (2.12M shares), RS INVESTMENT MANAGEMENT CO LLC (1.93M shares), and BlackRock Institutional Trust Company, N.A. (1.75M shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.